Similar articles

• Arginine deiminase from Mycoplasma arthritidis. Structure-activity relationships among substrates and competitive inhibitors.

  Smith DW, Ganaway RL, Fahrney DE. Smith DW, et al. J Biol Chem. 1978 Sep 10;253(17):6016-20. J Biol Chem. 1978. PMID: 681336
• Arginine deiminase: demonstration of two active sites and possible half-of-the-sites reactivity.

  Weickmann JL, Himmel ME, Smith DW, Fahrney DE. Weickmann JL, et al. Biochem Biophys Res Commun. 1978 Jul 14;83(1):107-13. doi: 10.1016/0006-291x(78)90404-7. Biochem Biophys Res Commun. 1978. PMID: 697802 No abstract available.
• Arginine deiminase of Mycoplasma hominis: cytoplasmic and membrane-associated forms.

  Lin JS. Lin JS. J Gen Microbiol. 1986 Jun;132(6):1467-74. doi: 10.1099/00221287-132-6-1467. J Gen Microbiol. 1986. PMID: 3806049
• Arginine Deiminase Enzyme Evolving as a Potential Antitumor Agent.

  Somani RR, Chaskar PK. Somani RR, et al. Mini Rev Med Chem. 2018;18(4):363-368. doi: 10.2174/1389557516666160817102701. Mini Rev Med Chem. 2018. PMID: 27538511 Review.
• Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug.

  Han RZ, Xu GC, Dong JJ, Ni Y. Han RZ, et al. Appl Microbiol Biotechnol. 2016 Jun;100(11):4747-60. doi: 10.1007/s00253-016-7490-z. Epub 2016 Apr 18. Appl Microbiol Biotechnol. 2016. PMID: 27087524 Review.